Captrust Financial Advisors Ptc Therapeutics, Inc. Transaction History

Captrust Financial Advisors

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$38.16 - $48.86 $201,713 - $258,273	5,286 New	5,286 $256,000
Q2 2022 Aug 16, 2022	SELL	$25.6 - $45.23 $1,715 - $3,030	-67 Reduced 37.43%	112 $4,000
Q1 2022 May 16, 2022	SELL	$33.33 - $44.6 $8,932 - $11,952	-268 Reduced 59.96%	179 $7,000
Q4 2021 Feb 14, 2022	SELL	$35.36 - $41.86 $1,555 - $1,841	-44 Reduced 8.96%	447 $18,000
Q3 2021 Nov 16, 2021	BUY	$37.01 - $44.74 $2,960 - $3,579	80 Added 19.46%	491 $18,000
Q2 2021 Aug 16, 2021	BUY	$37.95 - $49.37 $37 - $49	1 Added 0.24%	411 $17,000
Q1 2021 May 17, 2021	BUY	$46.8 - $68.92 $17,082 - $25,155	365 Added 811.11%	410 $19,000
Q2 2020 Aug 14, 2020	BUY	$42.56 - $54.98 $1,915 - $2,474	45 New	45 $2,000
Q4 2019 Feb 14, 2020	SELL	$32.22 - $50.07 $3,544 - $5,507	-110 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$33.82 - $48.17 $3,720 - $5,298	110 New	110 $4,000

223

78.1M

144K

58.7K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $2.81B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.